XML 68 R37.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stock-Based Compensation (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Stock options
Jun. 30, 2010
Stock options
Jun. 30, 2011
Stock options
Jun. 30, 2010
Stock options
May 31, 2010
Stock options, Bruker Corporation Stock Plan
Jun. 30, 2011
Stock options, Bruker Corporation Stock Plan
Oct. 31, 2009
Stock options, Bruker Energy and Supercon Technologies Stock Plan
Jun. 30, 2011
Stock options, Bruker Energy and Supercon Technologies Stock Plan
Jun. 30, 2011
Restricted stock
Jun. 30, 2010
Restricted stock
Jun. 30, 2011
Restricted stock
Jun. 30, 2010
Restricted stock
Stock-Based Compensation                                
Total stock-based compensation pre-tax $ 2.0 $ 1.7 $ 3.8 $ 3.3 $ 1.6 $ 1.5 $ 3.2 $ 2.8         $ 0.4 $ 0.2 $ 0.6 $ 0.5
Tax benefit 0.2 0.2 0.5 0.5                        
Total stock-based compensation net of tax 1.8 1.5 3.3 2.8                        
Award vesting period, minimum (in years)             3Y   3Y   3Y          
Award vesting period, maximum (in years)             5Y   5Y   5Y          
Risk-free interest rate, minimum (as a percent)             2.13% 1.73%                
Risk-free interest rate, maximum (as a percent)             3.12% 3.46%                
Expected life (in years)             6.5 6.5                
Volatility (as a percent)             57.20% 62.00%                
Expected dividend yield (as a percent)             0.00% 0.00%                
Number of common stock issued (in shares)                 8,000,000   1,600,000          
Stock option, Number of shares                                
Outstanding at the beginning of the period (in shares)             4,718,648                  
Granted (in shares)             162,500                  
Exercised (in shares)             (306,585)                  
Forfeited (in shares)             (95,755)                  
Outstanding at the end of the period (in shares)         4,478,808   4,478,808         800,000        
Exercisable at the end of the period (in shares)         2,498,976   2,498,976                  
Exercisable and expected to vest at the end of the period (in shares)         4,375,857   4,375,857                  
Stock options, Weighted average exercise price                                
Outstanding at the beginning of the period (in dollars per share)             $ 9.99                  
Granted (in dollars per share)         $ 18.45   $ 18.45                  
Exercised (in dollars per share)         $ 9.56   $ 9.56                  
Forfeited (in dollars per share)         $ 10.87   $ 10.87                  
Outstanding at the end of the period (in dollars per share)         $ 10.31   $ 10.31                  
Exercisable at the end of the period (in dollars per share)         $ 8.87   $ 8.87                  
Exercisable and expected to vest at the end of the period (in dollars per share)         $ 10.29   $ 10.29                  
Stock options, Weighted average remaining contractual life (years)                                
Outstanding at the end of the period (in years)         6.1   6.1                  
Exercisable at the end of the period (in years)             5.0                  
Exercisable and expected to vest at the end of the period (in years)             6.1                  
Stock options, Aggregate intrinsic value                                
Exercised (in dollars)             2.9                  
Outstanding at the end of the period (in dollars)         44.9   44.9                  
Exercisable at the end of the period (in dollars)         28.7   28.7                  
Exercisable and expected to vest at the end of the period (in dollars)         44.1   44.1                  
Fair value of the Company's common stock price         $ 20.36   $ 20.36                  
Restricted stock, Number of shares                                
Outstanding at the beginning of the period (in shares)                             247,258  
Granted (in shares)                             156,822  
Vested (in shares)                             (46,420)  
Forfeited (in shares)                             (300)  
Outstanding at the end of the period (in shares)                         357,360   357,360  
Restricted stock, Weighted-average grant date fair value                                
Non-vested at the beginning of the period (in dollars per share)                             $ 8.02  
Granted (in dollars per shares)                             $ 21.28  
Vested (in dollars per share)                             $ 7.69  
Forfeited (in dollars per share)                         $ 7.55   $ 7.55  
Non-vested at the end of the period (in dollars per share)                         $ 13.88   $ 13.88  
Expected pre-tax stock-based compensation expense                   $ 12.3   $ 1.5 $ 4.1   $ 4.1  
Weighted average remaining service period (in years)                   2.0   2.8     3.6